Inspira Health Network Expands Utilization of the DoseMeRx Platform
In this article:
Newly Acquired Mannington Site Adopts DoseMe to Maintain Standardization Strategy for Dosing Best Practices
Jupiter, FL – March 31, 2025
DoseMe, a leading provider of model-informed precision dosing (MIPD), today announced Inspira has expanded the implementation of the dosing platform to serve the newly acquired Mannington site. Inspira has used DoseMeRx since 2020 and integrates with EHR software for faster, efficient access to patient profiles for overall better quality of care.
Inspira Health is the region’s leading network of healthcare providers, delivering the full continuum of primary, acute and advanced care services. With 100 years of experience serving the Salem County area, Inspira Medical Center Mannington is dedicated to giving the community access to convenient, high-quality health care. Inspira is comprised of hospitals, comprehensive cancer centers, and multi-specialty health center locations serving communities throughout Southern New Jersey.
“We needed a tool to help standardize with the rest of the Inspira system and I have seen firsthand the positive effect DoseMeRx has had on Inspira’s patients at our other sites,” Chris Hearn, PharmD., MBA, Pharmacy Manager at Inspira Medical Center Mannington. “The decision was clear to implement this platform and it has already proven to offer the highest quality user experience and most desirable patient experience.”
Together with its medical staff of more than 1,300 physicians advanced practice providers and more than 7,800 employees, Inspira Health provides evidence-based care to help each patient achieve the best possible outcome.
“We continue to work side by side with Inspira to ensure the DoseMeRx integration exceeds their expectations and continues to support the overarching plan for ingenuity and new standards of care to improve our work every day,” said Paul Edwards, CEO at DoseMe. “Empowering teams from pharmacist, to nurses and doctors with the ultimate dosing platform is our mission, and we look forward to continuing to build upon this great partnership.”
DoseMeRx uses Bayesian dosing within a model-informed precision dosing software platform to recommend precise dosing to achieve clinical targets throughout the patient’s treatment course. Customers like Inspira contribute to the incredible results in significant improvements to mortality, risk, and patient outcomes. For more information, visit us at https://doseme-rx.com/bayesian-dosing
About DoseMe
DoseMe combines smart technology with science, leveraging clinically validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories